GRALV vs BBOT
Comparison between GRAIL Inc (GRALV, Company) and BridgeBio Oncology Therapeutics Inc Com (BBOT, Company).
GRALV vs BBOT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
GRALV
$673M
Winner
BBOT
$674M
Max Drawdown
Winner
GRALV
15.26%
BBOT
48.14%
Sharpe Ratio
Winner
GRALV
7.16
BBOT
0.14
5Y Beta
GRALV
N/A
BBOT
1.26
Industry
GRALV
N/A
BBOT
Biotechnology
P/E Ratio
GRALV
-3.30
Winner
BBOT
-5.02
Debt to Equity
GRALV
0.00%
BBOT
0.00%
Free Cash Flow Yield
GRALV
-49.01%
Winner
BBOT
-11.77%
P/S Ratio
GRALV
4.75
BBOT
N/A
P/B Ratio
Winner
GRALV
0.30
BBOT
1.90
GRALV vs BBOT - Historical Returns
Returns include dividend reinvestment.
1M
GRALV
N/A
BBOT
+10.80%
3M
GRALV
N/A
BBOT
-7.82%
6M
GRALV
N/A
BBOT
-23.44%
1Y
GRALV
N/A
BBOT
-9.64%
Max(CAGR)
Winner
GRALV
+1264121.32%
BBOT
-10.23%
GRALV vs BBOT - Annual Returns (2024 - 2026)
Returns include dividend reinvestment.
| Year | GRALV | BBOT |
|---|---|---|
| 2026 | N/A | -29.05% |
| 2025 | N/A | +29.74% |
| 2024 | +36.38% | N/A |
GRALV vs BBOT Drawdown Comparison
The maximum drawdown for GRALV was -15.26%, occurring on Jun 21, 2024. This drawdown has not yet recovered.
The maximum drawdown for BBOT was -48.14%, occurring on Jun 10, 2026. This drawdown has not yet recovered.
The current GRALV drawdown is -8.32%. The current BBOT drawdown is -36.49%.
| Rank | GRALV | BBOT |
|---|---|---|
| #1 | -15.26% Jun 20, 2024 - Jun 21, 2024 | -48.14% Nov 17, 2025 - Jun 10, 2026 |
| #2 | N/A | -26.82% Aug 18, 2025 - Sep 22, 2025 |
| #3 | N/A | -15.72% Oct 6, 2025 - Nov 10, 2025 |
| #4 | N/A | -6.99% Sep 22, 2025 - Oct 2, 2025 |
| #5 | N/A | -2.90% Nov 11, 2025 - Nov 14, 2025 |
| #6 | N/A | -0.64% Oct 2, 2025 - Oct 6, 2025 |
Correlation
Correlation between GRALV and BBOT is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: GRALV vs SPYBBOT vs SPY
More Comparisons
Compare with similar stocks